Acute Aerobic Exercise and Neuroplasticity in Depression
The Benefits of Acute Aerobic Exercise on Neuroplastic Potential in Depression
1 other identifier
interventional
38
1 country
1
Brief Summary
Depression is associated with a disruption in the mechanisms that regulate neuroplasticity. Effective treatment and rehabilitation of depression, and other neurological and neuropsychiatric disorders, relies on neuroplasticity. Thus, identifying therapies that enhance neuroplasticity (neuroplastic adaptation) are vital in the comprehensive treatment of depression. Aerobic exercise training has been demonstrated to have antidepressant properties and single bouts of aerobic exercise may provide short-term improvements in affective states in depression. Furthermore, acute aerobic exercise may enhance the response to known neuroplasticity-inducing paradigms. However, it is unclear if aerobic exercise can influence neuroplasticity in depression and the neurobiological mechanisms underlying acute neuroplastic changes are not well understood in depressed and healthy cohorts. Thus, the purpose of this project is to examine the acute effects of aerobic exercise on neuroplastic, neurobiological, and mood indices of depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started May 2016
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 12, 2016
CompletedFirst Posted
Study publicly available on registry
July 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedJanuary 30, 2019
January 1, 2019
2.6 years
July 12, 2016
January 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in peak to peak MEP amplitude (mV)
From baseline to one hour post-PAS
Secondary Outcomes (2)
Change in serum BDNF (ng/ml)
From baseline to one hour post-exercise
Change in serum cortisol (ng/ml)
From baseline to one hour post-exercise
Study Arms (1)
Depressed and non-depressed controls
EXPERIMENTALAll participants will participate in three different conditions: Low intensity aerobic exercise and paired associative stimulation, high intensity aerobic exercise and paired associative stimulation, no exercise control and paired associative stimulation. The order of conditions will be randomized.
Interventions
Aerobic exercise will be performed on a stationary cycle ergometer for 15 minutes at an intensity of 35% heart rate reserve or 70% heart rate reserve. During the control condition the participant will remain seated on the stationary cycle for 15 minutes and will not perform exercise.
After aerobic exercise participants will receive a paired associative stimulation (PAS) paradigm. PAS consists of paired brain and peripheral nerve stimuli. Participants will receive 200 paired stimuli. Peripheral nerve stimulation will be delivered to the median nerve at the level of the wrist via electrical stimulation at 300% perceptual threshold. Brain stimulation will be delivered via transcranial magnetic stimulation (TMS) over the hand knob of the motor cortex at an intensity that elicits a 1mV response in the contralateral abductor pollicis brevis muscle. During each paired stimulation, peripheral nerve stimulation will precede the TMS stimulation by 25ms.
Eligibility Criteria
You may qualify if:
- For all:
- age 18-50 year old.
- ability to provide informed consent.
- meets criteria for unipolar depression assessed using the Mini-international Neuropsychiatric Interview (MINI)
- a Montgomery Asberg Depression Rating Scale (MADRS) score of 20 or greater
- current depressive episode began no longer than 3 years earlier
- psychoactive drug free or have maintained a stable dose of up to one antidepressant medication for four weeks prior to study participation
- does not meet criteria for unipolar depression assessed using the MINI
- a MADRS score of 6 or less
- no history or previous diagnosis of depression
You may not qualify if:
- primary diagnosis of another Axis 1 disorder
- secondary diagnosis of a psychotic disorder, cognitive disorder, substance-related disorder, or obsessive compulsive disorder
- illicit drug use or alcohol abuse
- current smoker
- history of seizures
- other diagnosed neurological or musculoskeletal disorder/injury, uncontrolled cardiovascular or metabolic disease
- resting blood pressure \> 200mmHg systolic or 100mmHg diastolic
- electronic or metal implants
- current participation in a structured exercise program
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stroke Recovery Research Center
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris Gregory, P.T., Ph.D.
Medical University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2016
First Posted
July 21, 2016
Study Start
May 1, 2016
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
January 30, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share